olympiA

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

olympiA

Mar 21, 2025, 17:36 | Science

Pierre Foidart: Patients-related outcomes in OlympiA

Pierre Foidart, Medical oncologist and Head of Clinic at the University Hospital of Liège (CHU…

Dec 13, 2024, 13:58 | Blog

Olubukola Ayodele: OlympiA Update - Median follow up at 6.1 years

Olubukola Ayodele, Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, shared a…

Dec 12, 2024, 20:07 | Blog

Matteo Lambertini: Major benefit of adjuvant olaparib for BRCA carriers with high-risk early Breast Cancer

Matteo Lambertini shared on X: "Presented at SABCS24 updated data from the olympiA trial showing…

Dec 12, 2024, 16:38 | Insight

Yara Abdou: OlympiA, Updated analysis

Yara Abdou, Assistant Professor at the University of North Carolina, shared a post on X:…

Dec 12, 2024, 14:12 | Blog

SABCS24 Day 2 Highlights from Oncology Brothers

Oncology Brothers posted on X: "SABCS24 Day 2 Highlights 1. EMBER3: Oral SERD in HR+…

All: 5 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023